Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:37 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 542919 | NSE: ARTEMISMED

Artemis Medicare Services Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹205.57Fairly Valued by 7.82%vs CMP ₹223.00

P/E (35.5) × ROE (12.9%) × BV (₹56.00) × DY (0.20%)

₹114.52Overvalued by 48.65%vs CMP ₹223.00
MoS: -94.7% (Negative)Confidence: 63/100 (Moderate)Models: 1 Under, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹252.0023%Under (+13%)
Graham NumberEarnings₹92.6317%Over (-58.5%)
Earnings PowerEarnings₹10.6911%Over (-95.2%)
DCFCash Flow₹133.1111%Over (-40.3%)
Net Asset ValueAssets₹56.077%Over (-74.9%)
EV/EBITDAEnterprise₹104.679%Over (-53.1%)
Earnings YieldEarnings₹68.107%Over (-69.5%)
ROCE CapitalReturns₹21.837%Over (-90.2%)
Revenue MultipleRevenue₹57.716%Over (-74.1%)
Consensus (9 models)₹114.52100%Overvalued
Key Drivers: Wide model spread (₹11–₹252) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 22.6%

*Investments are subject to market risks

Analyst Summary

Artemis Medicare Services Ltd operates in the Hospitals & Medical Services segment, NSE: ARTEMISMED | BSE: 542919, current market price is ₹223.00, market cap is 3,528 Cr.. At a glance, stock P/E is 35.5, ROE is 12.9 %, ROCE is 14.9 %, book value is 56.0, dividend yield is 0.20 %. The latest intrinsic value estimate is ₹114.52, around 48.6% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹913 Cr versus the prior period change of 8.0%, while latest net profit is about ₹83 Cr with a prior-period change of 69.4%. This analysis page also carries profit and loss, shareholding pattern, ratio panels, mutual fund holdings data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 306/203, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisArtemis Medicare Services Ltd. is a Public Limited Listed company incorporated on 18/05/2004 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L85110DL2004PLC126414 and registration number is 126414. Currently Company is…

This summary is generated from the stock page data available for Artemis Medicare Services Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

67
Artemis Medicare Services Ltd scores 67/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health68/100 · Strong
ROCE 14.9% GoodROE 12.9% GoodD/E 0.33 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding up 12.16% (6mo) AccumulatingDII holding down 2.13% MF sellingPromoter decreased by 8.15% Caution
Earnings Quality65/100 · Strong
OPM expanding (13% → 16%) Improving
Quarterly Momentum80/100 · Strong
Revenue (4Q): +12% YoY GrowingProfit (4Q): +44% YoY Strong
Industry Rank65/100 · Strong
P/E 35.5 vs industry 75.2 Cheaper than peersROCE 14.9% vs industry 14.7% Average3Y sales CAGR: 19% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:37 am

Market Cap 3,528 Cr.
Current Price 223
Intrinsic Value₹114.52
High / Low 306/203
Stock P/E35.5
Book Value 56.0
Dividend Yield0.20 %
ROCE14.9 %
ROE12.9 %
Face Value 1.00
PEG Ratio1.57

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Artemis Medicare Services Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Shalby Ltd 1,507 Cr. 140 275/126187 92.80.00 %6.12 %0.62 % 10.0
Thyrocare Technologies Ltd 5,762 Cr. 362 538/22043.8 32.41.93 %26.5 %17.4 % 10.0
Sakar Healthcare Ltd 1,147 Cr. 516 578/22045.5 1360.00 %8.54 %6.48 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Artemis Medicare Services Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 182181187201217210217217235227235250270
Expenses 158156163174184179181181193190199209220
Operating Profit 24262527333236364237364150
OPM % 13%14%13%14%15%15%17%16%18%16%15%16%19%
Other Income 11212224891278
Interest 5556788888877
Depreciation 788991010101111111111
Profit before tax 14141413191619223127293040
Tax % 31%23%23%26%27%29%28%24%27%23%20%29%25%
Net Profit 10111010141214172321232130
EPS in Rs 0.730.800.780.731.010.851.021.241.641.511.691.542.16

Last Updated: January 2, 2026, 11:00 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 10:14 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2613684024595035475634025457148459131,022
Expenses 234325359406442480501367477620717763851
Operating Profit 27434353606662356894128150170
OPM % 11%12%11%11%12%12%11%9%12%13%15%16%17%
Other Income 135432473773331
Interest 13129991113121119303028
Depreciation 9121215182022212129384345
Profit before tax 72127323537329395368109128
Tax % 0%12%21%16%24%44%36%20%16%25%28%24%
Net Profit 719222727212073340498397
EPS in Rs 0.320.881.031.291.270.981.540.542.462.963.626.076.81
Dividend Payout % 0%0%0%0%0%0%0%0%0%15%12%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)171.43%15.79%22.73%0.00%-22.22%-4.76%-65.00%371.43%21.21%22.50%69.39%
Change in YoY Net Profit Growth (%)0.00%-155.64%6.94%-22.73%-22.22%17.46%-60.24%436.43%-350.22%1.29%46.89%

Artemis Medicare Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:10%
5 Years:10%
3 Years:19%
TTM:10%
Compounded Profit Growth
10 Years:16%
5 Years:32%
3 Years:36%
TTM:57%
Stock Price CAGR
10 Years:%
5 Years:69%
3 Years:53%
1 Year:-16%
Return on Equity
10 Years:10%
5 Years:10%
3 Years:12%
Last Year:13%

Last Updated: September 4, 2025, 11:40 pm

Balance Sheet

Last Updated: December 4, 2025, 12:58 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 21212121210.0013131313141414
Reserves 116135163183210280301308348393438828873
Borrowings 11085689491114108137190268305280274
Other Liabilities 669093124130160159130145207191221255
Total Liabilities 3133313454224525555815896978829481,3431,416
Fixed Assets 236239249283309381387372476584699729780
CWIP 00127434956816495334037
Investments 00000024612151515
Other Assets 779194112100124137132152192200559584
Total Assets 3133313454224525555815896978829481,3431,416

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 455320587241562761129108139
Cash from Investing Activity + -12-10-14-74-67-50-22-34-106-153-90-388
Cash from Financing Activity + -21-35-2419-1014-33134430-26277
Net Cash Flow 117-183-4526-27-828
Free Cash Flow 45374-1711-17372-45-53646
CFO/OP 145%127%48%112%121%76%97%83%114%140%95%102%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-83.00-42.00-25.00-41.00-31.00-48.00-46.00-102.00-122.00-174.00-177.00-130.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 413949484052504847433637
Inventory Days 26262119
Days Payable 237195189187
Cash Conversion Cycle -171-129-120-1204052504847433637
Working Capital Days -70-59-31-44-53-51-36-35-25-45-29-29
ROCE %8%14%15%16%15%14%11%4%10%11%14%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 68.91%68.03%68.03%68.03%68.03%67.51%67.17%67.17%67.17%66.53%66.53%58.38%
FIIs 0.00%0.07%0.09%0.11%0.10%0.16%0.21%0.65%0.31%0.24%0.37%12.47%
DIIs 1.37%1.41%1.51%1.96%2.61%3.45%3.60%4.51%5.04%4.76%4.27%2.91%
Government 7.27%7.18%7.18%7.18%7.18%7.12%7.09%7.09%7.09%7.02%7.02%6.16%
Public 22.43%23.30%23.18%22.72%22.08%21.76%21.93%20.59%20.39%21.45%21.81%20.07%
No. of Shareholders 18,10019,08220,52922,37519,99319,79526,05427,00428,39731,61433,55931,602

Shareholding Pattern Chart

No. of Shareholders

Artemis Medicare Services Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HSBC Focused Fund 1,250,000 1.86 30.99N/AN/AN/A
Bandhan Small Cap Fund 609,551 0.08 15.11421,0792025-12-08 06:13:2644.76%
LIC MF Small Cap Fund 404,858 1.71 10.04122,7012025-12-08 02:25:41229.95%
LIC MF Focused Fund 211,797 3.24 5.25199,8522026-02-23 04:52:515.98%
LIC MF Healthcare Fund 93,529 2.95 2.32108,8322025-12-15 00:16:01-14.06%
LIC MF Childrens Fund 5,111 0.86 0.13N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.0010.00
Basic EPS (Rs.) 5.373.622.892.404.90
Diluted EPS (Rs.) 5.313.532.792.294.90
Cash EPS (Rs.) 9.256.585.154.0520.91
Book Value[Excl.RevalReserv]/Share (Rs.) 55.9028.4625.3722.23243.05
Book Value[Incl.RevalReserv]/Share (Rs.) 60.8833.4730.4027.29243.05
Revenue From Operations / Share (Rs.) 68.0964.6754.9841.91308.51
PBDIT / Share (Rs.) 13.4310.317.555.3929.26
PBIT / Share (Rs.) 10.157.345.243.7113.01
PBT / Share (Rs.) 7.825.043.772.815.69
Net Profit / Share (Rs.) 5.973.622.832.374.65
NP After MI And SOA / Share (Rs.) 6.003.622.882.404.90
PBDIT Margin (%) 19.7215.9413.7312.869.48
PBIT Margin (%) 14.9011.359.538.864.21
PBT Margin (%) 11.497.796.866.701.84
Net Profit Margin (%) 8.775.595.155.651.50
NP After MI And SOA Margin (%) 8.815.595.235.731.58
Return on Networth / Equity (%) 10.7412.9111.4910.872.02
Return on Capital Employeed (%) 12.2312.6710.058.603.57
Return On Assets (%) 6.085.054.264.481.08
Long Term Debt / Equity (X) 0.270.590.630.550.33
Total Debt / Equity (X) 0.310.660.710.620.33
Asset Turnover Ratio (%) 0.800.930.890.830.68
Current Ratio (X) 2.490.970.820.910.92
Quick Ratio (X) 2.450.920.750.820.84
Inventory Turnover Ratio (X) 93.410.000.000.000.00
Dividend Payout Ratio (NP) (%) 7.4512.440.000.000.00
Dividend Payout Ratio (CP) (%) 4.826.830.000.000.00
Earning Retention Ratio (%) 92.5587.560.000.000.00
Cash Earning Retention Ratio (%) 95.1893.170.000.000.00
Interest Coverage Ratio (X) 5.784.485.155.963.00
Interest Coverage Ratio (Post Tax) (X) 3.572.572.933.621.23
Enterprise Value (Cr.) 3636.782505.471107.95765.31372.04
EV / Net Operating Revenue (X) 3.882.851.501.380.91
EV / EBITDA (X) 19.6817.8910.9410.739.60
MarketCap / Net Operating Revenue (X) 4.042.631.241.100.71
Retention Ratios (%) 92.5487.550.000.000.00
Price / BV (X) 4.926.062.722.080.91
Price / Net Operating Revenue (X) 4.042.631.241.100.71
EarningsYield 0.020.020.040.050.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Artemis Medicare Services Ltd. is a Public Limited Listed company incorporated on 18/05/2004 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L85110DL2004PLC126414 and registration number is 126414. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 913.26 Cr. and Equity Capital is Rs. 13.76 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesPlot No. 14, Delhi Delhi 110075Contact not found
Management
NamePosition Held
Mr. Onkar KanwarChairman & Non-Exe.Director
Dr.(Mrs.) Devlina ChakravartyManaging Director
Mr. Neeraj KanwarNon Executive Director
Mrs. Shalini Kanwar ChandNon Executive Director
Mr. Sunam SarkarNon Executive Director
Ms. Deepa Gopalan WadhwaIndependent Director
Mr. Sunil TandonIndependent Director
Mr. Sanjib SenIndependent Director
Mr. Vinod RaiIndependent Director
Mr. Akshaykumar Narendrasinhji ChudasamaIndependent Director
Ms. Pallavi Shardul ShroffIndependent Director

FAQ

What is the intrinsic value of Artemis Medicare Services Ltd and is it undervalued?

As of 20 April 2026, Artemis Medicare Services Ltd's intrinsic value is ₹114.52, which is 48.65% lower than the current market price of ₹223.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (12.9 %), book value (₹56.0), dividend yield (0.20 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd is trading at ₹223.00 as of 20 April 2026, with a FY2026-2027 high of ₹306 and low of ₹203. The stock is currently near its 52-week low. Market cap stands at ₹3,528 Cr..

How does Artemis Medicare Services Ltd's P/E ratio compare to its industry?

Artemis Medicare Services Ltd has a P/E ratio of 35.5, which is below the industry average of 75.17. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Artemis Medicare Services Ltd financially healthy?

Key indicators for Artemis Medicare Services Ltd: ROCE of 14.9 % is moderate. Dividend yield is 0.20 %.

Is Artemis Medicare Services Ltd profitable and how is the profit trend?

Artemis Medicare Services Ltd reported a net profit of ₹83 Cr in Mar 2025 on revenue of ₹913 Cr. Compared to ₹33 Cr in Mar 2022, the net profit shows an improving trend.

Does Artemis Medicare Services Ltd pay dividends?

Artemis Medicare Services Ltd has a dividend yield of 0.20 % at the current price of ₹223.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Artemis Medicare Services Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports